Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |